Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

New program launched to accelerate access to personalized therapies for children with rare conditions

Today, Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop a pathway for children with rare conditions to access individualized therapies.

4 Dec 2023

Groundbreaking manufacturing process could revolutionize lower limb socket production

Lower limb prosthetic sockets could soon be printed in remote locations and even in users' homes, thanks to a groundbreaking process developed by manufacturing experts at Loughborough University.

4 Dec 2023

‘Forever chemicals’ found in freshwater fish, yet most states don’t warn residents

Bill Eisenman has always fished. "Growing up, we ate whatever we caught — catfish, carp, freshwater drum," he said. "That was the only real source of fish in our diet as a family, and we ate a lot of it."

1 Dec 2023

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited bioavailability. Nanocarriers like liposomes and nanoparticles improve TCM delivery, offering greater therapeutic effectiveness and reduced side effects, but face challenges in biocompatibility and stability for clinical use.

30 Nov 2023

Novel method can detect contaminants in T-cell cultures within 24 hours

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE) and Massachusetts Institute of Technology (MIT), have developed a novel method capable of identifying contaminants in T-cell cultures within 24 hours.

27 Nov 2023

Synthetic biologists develop versatile platform for targeted drug delivery

In recent years, cell and gene therapies have shown significant promise for treating cancer, cystic fibrosis, diabetes, heart disease, HIV/AIDS and other difficult-to-treat diseases.

27 Nov 2023

Study uncovers a previously unknown molecular pathway to halt lung cancer

A new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its tracks.

27 Nov 2023

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).

27 Nov 2023

Inciner8 supports people affected by Sudan conflict with landmark order

...

From Inciner8 Limited 24 Nov 2023

Balancing health and economy: A new model to assess pandemic response strategies

In order to minimize the impact of a pandemic on the economy, which would be more effective: a lockdown or letting individuals spontaneously reduce their risk of infection?

23 Nov 2023

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

In this Interview, Dr. Fang-Yi Chu talks to NewsMed about the role of transmembrane proteins in targeting oncology research.

From Sino Biological Inc. 23 Nov 2023

Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

...

From Metrohm Middle East FZC 22 Nov 2023

Eating more ultra-processed foods may increase risk of upper aerodigestive tract cancers

Eating more ultra-processed foods (UPFs) may be associated with a higher risk of developing cancers of upper aerodigestive tract (including the mouth, throat and oesophagus), according to a new study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC).

22 Nov 2023

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

MaxCyte, Inc. today announced that it has joined the Alliance for mRNA Medicines, as a founding member.

From MaxCyte, Inc. 22 Nov 2023

Sugary drinks linked to higher dementia risk, new study from UK Biobank reveals

The study finds that consuming free sugars, especially through beverages like fruit drinks, sodas, and milk-based drinks, is associated with an increased risk of dementia, while free sugars from solid foods show no significant link to dementia risk.

20 Nov 2023

Novel 3D-printed implant could revolutionize infection control in surgery

A novel surgical implant developed by Washington State University researchers was able to kill 87% of the bacteria that cause staph infections in laboratory tests, while remaining strong and compatible with surrounding tissue like current implants.

20 Nov 2023

US military says national security depends on ‘forever chemicals’

The Department of Defense relies on hundreds, if not thousands, of weapons and products such as uniforms, batteries, and microelectronics that contain PFAS, a family of chemicals linked to serious health conditions.

20 Nov 2023

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with the Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute (BTI) and National University Health System (NUHS), have developed a groundbreaking technology capable of extracting mesenchymal stem cells (MSCs) directly from pure bone marrow – also known as bone marrow aspirate (BMA), a pivotal source of MSCs – without dilution.

20 Nov 2023

New economic-pandemic model helps assess effectiveness of pandemic policies

Epidemic-Economic Model Provides Answers To Key Pandemic Policy Questions

16 Nov 2023

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance for mRNA Medicines (AMM), as a founding member.

From MaxCyte, Inc. 16 Nov 2023

Manufacturing News and Research

Further Reading

New program launched to accelerate access to personalized therapies for children with rare conditions

Groundbreaking manufacturing process could revolutionize lower limb socket production

‘Forever chemicals’ found in freshwater fish, yet most states don’t warn residents

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

Novel method can detect contaminants in T-cell cultures within 24 hours

Synthetic biologists develop versatile platform for targeted drug delivery

Study uncovers a previously unknown molecular pathway to halt lung cancer

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Inciner8 supports people affected by Sudan conflict with landmark order

Balancing health and economy: A new model to assess pandemic response strategies

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

Eating more ultra-processed foods may increase risk of upper aerodigestive tract cancers

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

Sugary drinks linked to higher dementia risk, new study from UK Biobank reveals

Novel 3D-printed implant could revolutionize infection control in surgery

US military says national security depends on ‘forever chemicals’

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

New economic-pandemic model helps assess effectiveness of pandemic policies

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News